The text discusses adjuvant chemotherapy options for stage II colon cancer based on prognostic factors. For MSS status, low-toxicity regimens like capecitabine or LV5FU2 for 6 months are recommended. For high-risk MSS cases, oxaliplatin-based regimens may be considered for patients under 70 with specific factors. For MSI pT4b, adjuvant chemotherapy with fluoropyrimidines and oxaliplatin is recommended.